T. John

发表

Genetic material should be routinely collected in clinical vaccine trials--high consent rates can be achieved across all age groups.

J. Trück, A. Pollard, M. Snape, 2013, Vaccine.

University of Birmingham Using a human challenge model of infection to measure vaccine efficacy

G. Dougan, M. Levine, S. Lockhart, 2016 .

Predictors of immune response and reactogenicity to AS03B-adjuvanted split virion and non-adjuvanted whole virion H1N1 (2009) pandemic influenza vaccines.

S. Faust, A. Pollard, C. Oeser, 2011, Vaccine.

Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study

S. Faust, A. Pollard, C. Oeser, 2010, BMJ : British Medical Journal.

Open-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03(B)/oil-in-water emulsion-adjuvanted (AS03(B)) split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK children 6 months to 12 years of age.

C. Oeser, N. Andrews, S. Ladhani, 2010, Health technology assessment.

Expediting clinical trials in a pandemic

S. Faust, A. Pollard, A. Finn, 2009, BMJ : British Medical Journal.

Humoral and cellular immune responses to split-virion H5N1 influenza vaccine in young and elderly adults.

P. van Damme, A. Pollard, G. Leroux-Roels, 2009, Vaccine.

A Cross-Sectional Observational Study of Pneumococcal Carriage in Children, Their Parents, and Older Adults Following the Introduction of the 7-Valent Pneumococcal Conjugate Vaccine

Shannon N. Fenlon, D. Crook, J. Hinds, 2015, Medicine.

B Cell Memory to a Serogroup C Meningococcal Conjugate Vaccine in Childhood and Response to Booster: Little Association with Serum IgG Antibody

Ly-Mee Yu, A. Pollard, N. Curtis, 2012, The Journal of Immunology.

Persistence of Antibody Response Following a Booster Dose of Hib-MenC-TT Glycoconjugate Vaccine to Five Years: A Follow-up Study

Ly-Mee Yu, A. Pollard, M. Snape, 2012, The Pediatric infectious disease journal.

The predicted persistence and kinetics of antibody decline 9years after pre-school booster vaccination in UK children.

Ly-Mee Yu, A. Pollard, M. Voysey, 2016, Vaccine.

Evaluation of Haemophilus influenzae Type b Vaccine for Routine Immunization in Nepali Infants

D. Murdoch, D. Kelly, Ly-Mee Yu, 2012, The Pediatric infectious disease journal.

Immunogenicity of Two Investigational Serogroup B Meningococcal Vaccines in the First Year of Life: A Randomized Comparative Trial

Ly-Mee Yu, A. Pollard, D. Toneatto, 2010, The Pediatric infectious disease journal.

Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy.

A. Pollard, D. Toneatto, M. Snape, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Persistence of Bactericidal Antibodies to 5 Years of Age After Immunization With Serogroup B Meningococcal Vaccines at 6, 8, 12 and 40 Months of Age

A. Pollard, M. Voysey, D. Toneatto, 2014, The Pediatric infectious disease journal.

Persistence of specific bactericidal antibodies at 5 years of age after vaccination against serogroup B meningococcus in infancy and at 40 months

Ly-Mee Yu, A. Pollard, D. Toneatto, 2015, Canadian Medical Association Journal.

Immunogenicity and Reactogenicity of a 13-Valent-pneumococcal Conjugate Vaccine Administered at 2, 4, and 12 Months of Age: A Double-blind Randomized Active-controlled Trial

E. Emini, W. Gruber, Ly-Mee Yu, 2010, The Pediatric infectious disease journal.

Bactericidal Antibody Persistence 2 Years After Immunization With 2 Investigational Serogroup B Meningococcal Vaccines at 6, 8 and 12 Months and Immunogenicity of Preschool Booster Doses: A Follow-on Study to a Randomized Clinical Trial

J. Philip, Ly-Mee Yu, A. Pollard, 2013, The Pediatric infectious disease journal.

Immunisation errors reported to a vaccine advice service: intelligence to improve practice.

K. Ford, N. McCarthy, A. Pollard, 2014, Quality in primary care.

Persistence of Immunity Following a Booster Dose of Haemophilus Influenzae Type B-Meningococcal Serogroup C Glycoconjugate Vaccine: Follow-up of a Randomized Controlled Trial

Ly-Mee Yu, A. Pollard, M. Snape, 2011, The Pediatric infectious disease journal.

Long-term persistence of immunity and B-cell memory following Haemophilus influenzae type B conjugate vaccination in early childhood and response to booster.

N. Curtis, K. Perrett, C. Jin, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Persistence of Serum Bactericidal Antibody One Year After a Booster Dose of Either a Glycoconjugate or a Plain Polysaccharide Vaccine Against Serogroup C Neisseria meningitidis Given to Adolescents Previously Immunized With a Glycoconjugate Vaccine

D. Kelly, Ly-Mee Yu, A. Pollard, 2011, The Pediatric infectious disease journal.

Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primary-school children in 1999-2000 and response to a booster: a phase 4 clinical trial.

Ly-Mee Yu, A. Pollard, N. Curtis, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Haemophilus inﬂuenzae Type b Carriage and Novel Bacterial Population Structure among Children in Urban Kathmandu, Nepal (cid:1)

D. Kelly, D. Griffiths, S. Dongol, 2011 .

School-aged children: a reservoir for continued circulation of Haemophilus influenzae type b in the United Kingdom.

D. Crook, N. McCarthy, E. Moxon, 2008, The Journal of infectious diseases.

The B-cell response to a primary and booster course of MenACWY-CRM₁₉₇ vaccine administered at 2, 4 and 12 months of age.

T. Odrljin, D. Kelly, G. Blanchard-Rohner, 2013, Vaccine.

Immunogenicity and Immune Memory of a Nonadjuvanted Quadrivalent Meningococcal Glycoconjugate Vaccine in Infants

J. Langley, K. Ford, Ly-Mee Yu, 2009, The Pediatric infectious disease journal.

Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulations.

J. Langley, C. Gill, Ly-Mee Yu, 2012, Vaccine.

Seroprevalence and Placental Transmission of Maternal Antibodies Specific for Neisseria meningitidis Serogroups A, C, Y and W135 and Influence of Maternal Antibodies on the Immune Response to a Primary Course of MenACWY-CRM Vaccine in the United Kingdom

D. Kelly, K. Ford, G. Blanchard-Rohner, 2013, The Pediatric infectious disease journal.

An Outpatient, Ambulant-Design, Controlled Human Infection Model Using Escalating Doses of Salmonella Typhi Challenge Delivered in Sodium Bicarbonate Solution

J. Farrar, G. Dougan, K. Holt, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial.

J. Langley, K. Ford, Ly-Mee Yu, 2008, JAMA.

Exonic single nucleotide polymorphisms within TLR3 associated with infant responses to serogroup C meningococcal conjugate vaccine.

A. Pollard, A. Hill, M. Snape, 2014, Vaccine.

The Magnitude of the Antibody and Memory B Cell Responses during Priming with a Protein-Polysaccharide Conjugate Vaccine in Human Infants Is Associated with the Persistence of Antibody and the Intensity of Booster Response1

D. Kelly, Ly-Mee Yu, A. Pollard, 2008, The Journal of Immunology.

Booster Response Persistence of Antibody and the Intensity of Human Infants Is Associated with the Protein-Polysaccharide Conjugate Vaccine in B Cell Responses during Priming with a The Magnitude of the Antibody and Memory

D. Kelly, Ly-Mee Yu, A. Pollard, 2008 .

Using a Human Challenge Model of Infection to Measure Vaccine Efficacy: A Randomised, Controlled Trial Comparing the Typhoid Vaccines M01ZH09 with Placebo and Ty21a

G. Dougan, M. Levine, S. Lockhart, 2016, PLoS neglected tropical diseases.

Haemophilus influenzae Type b Carriage and Novel Bacterial Population Structure among Children in Urban Kathmandu, Nepal

D. Murdoch, D. Kelly, A. Pollard, 2011, Journal of Clinical Microbiology.

Streptococcus pneumoniae Carriage Prevalence in Nepal: Evaluation of a Method for Delayed Transport of Samples from Remote Regions and Implications for Vaccine Implementation

D. Murdoch, D. Kelly, Ly-Mee Yu, 2014, PloS one.

Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study

D. Kelly, Ly-Mee Yu, A. Pollard, 2008, BMJ : British Medical Journal.

Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose

Ly-Mee Yu, A. Pollard, D. Toneatto, 2013, Canadian Medical Association Journal.

Meningococcal carriage in adolescents in the United Kingdom to inform timing of an adolescent vaccination strategy.

N. Kitchin, K. Jansen, S. Clarke, 2015, The Journal of infection.

Immunogenicity and Reactogenicity of a 13-Valent-pneumococcal Conjugate Vaccine Administered at 2, 4, and 12 Months of Age

E. Emini, W. Gruber, S. Faust, 2010 .

H1N1 Antibody Persistence 1 Year After Immunization With an Adjuvanted or Whole-Virion Pandemic Vaccine and Immunogenicity and Reactogenicity of Subsequent Seasonal Influenza Vaccine: A Multicenter Follow-on Study

S. Faust, A. Pollard, C. Oeser, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Children’s consent and paediatric research: is it appropriate for healthy children to be the decision-makers in clinical research?

J. Savulescu, A. Pollard, T. John, 2007, Archives of Disease in Childhood.

The B-cell response to a primary and booster course of MenACWY-CRM₁₉₇ vaccine administered at 2, 4 and 12 months of age.

T. Odrljin, D. Kelly, G. Blanchard-Rohner, 2013, Vaccine.

Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial.

J. Langley, K. Ford, Ly-Mee Yu, 2008, JAMA.

ImmunogenicityofaTetravalentMeningococcal Glycoconjugate Vaccine in Infants

J. Langley, K. Ford, A. Pollard, 2006 .